Physician profile
Christopher J Higgins
NPI 1417123274
$12,633.05
in general payments reported to CMS, 2019-2025
41 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $1,131 · 2021: $2,139 · 2022: $1,362 · 2023: $4,183 · 2024: $1,881 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,726 · Travel and Lodging: $2,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,725.57 |
| Travel and Lodging | $2,414.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,923.03 | 2020-2025 | Watchman Flx, Bodyguardian, Watchman |
| Medtronic, INC. | $1,578.91 | 2021-2025 | Abre, Hawkone, Resolute Onyx |
| Esperion Therapeutics, INC. | $722.23 | 2020-2024 | Nexletol |
| Abbott Laboratories | $698.00 | 2019-2025 | Mitraclip, Cardiomems, Esprit |
| Astrazeneca Pharmaceuticals LP | $690.27 | 2019-2024 | Farxiga, Brilinta |
| Abiomed | $628.46 | 2023-2025 | Impella |
| Medtronic Vascular, INC. | $582.29 | 2019-2020 | |
| Angiodynamics, INC. | $484.62 | 2021 | |
| Heartflow, INC. | $409.51 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $357.51 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $348.17 | 2019-2024 | |
| Edwards Lifesciences Corporation | $339.99 | 2019-2024 | Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $271.68 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $268.80 | 2019-2024 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $252.43 | 2019-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $240.42 | 2019-2023 | Repatha |
| Cardinal Health 200 LLC | $203.95 | 2019-2020 | |
| Cvrx, INC. | $188.91 | 2021-2024 | Barostim Neo System |
| Shockwave Medical, INC | $172.80 | 2025 | |
| Terumo Medical Corporation | $155.95 | 2021-2025 | Heartrail, R2p Misago, Angio-Seal |
| Ge Healthcare | $124.85 | 2024-2025 | |
| Teleflex LLC | $105.39 | 2019-2022 | |
| Pfizer INC. | $100.29 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $99.35 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $95.70 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $93.25 | 2022-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $79.87 | 2022-2023 | Opsumit |
| Inari Medical, INC. | $78.92 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lexicon Pharmaceuticals, INC. | $58.28 | 2023 | Inpefa |
| Cardiovascular Systems INC. | $43.28 | 2019 | |
| Zynex Medical, INC. | $36.47 | 2025 | Nexwave |
| Atricure, INC. | $33.72 | 2024 | |
| Cordis US Corp. | $31.58 | 2023-2024 | Mynxgrip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.47 | 2019-2020 | |
| Scpharmaceuticals INC. | $20.63 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $20.00 | 2022 | |
| Gilead Sciences, INC. | $16.15 | 2019 | |
| Cook Medical LLC | $15.36 | 2025 | Icast Covered Stent System, 6mmx22mmx120cm |
| Chiesi USA, INC. | $14.69 | 2020 | |
| Impulse Dynamics (USA) INC. | $13.12 | 2023 | Optimizer |
| Biomerieux INC | $7.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.